{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:50:35Z","timestamp":1762505435249},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"12","content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000246","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T18:35:57Z","timestamp":1230748557000},"page":"e1000246","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Mathematical Framework for the Selection of an Optimal Set of Peptides for Epitope-Based Vaccines"],"prefix":"10.1371","volume":"4","author":[{"given":"Nora C.","family":"Toussaint","sequence":"first","affiliation":[]},{"given":"Pierre","family":"D\u00f6nnes","sequence":"additional","affiliation":[]},{"given":"Oliver","family":"Kohlbacher","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2008,12,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults.","volume":"25","author":"M Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.vaccine.2006.07.050","article-title":"Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.","volume":"25","author":"PA Goepfert","year":"2007","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ymthe.2006.01.013","article-title":"Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage nonsmall-cell lung cancer.","volume":"13","author":"J Nemunaitis","year":"2006","journal-title":"Mol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1016\/j.vaccine.2005.08.013","article-title":"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.","volume":"24","author":"M Mancini-Bourgine","year":"2006","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design.","volume":"6","author":"AW Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.cji.0000211338.99137.4f","article-title":"Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies.","volume":"30","author":"S Depil","year":"2007","journal-title":"J Immunother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CJI.0b013e31816dad10","article-title":"A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer.","volume":"31","author":"KA Chianese-Bullock","year":"2008","journal-title":"J Immunother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-07-1881","article-title":"Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.","volume":"14","author":"GG Kenter","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1158\/1078-0432.CCR-05-0559","article-title":"Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.","volume":"11","author":"N Yajima","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1200\/JCO.2003.10.005","article-title":"Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.","volume":"21","author":"CL Slingluff","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1158\/1078-0432.CCR-07-0486","article-title":"Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.","volume":"13","author":"CL Slingluff","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00262-003-0480-x","article-title":"The T\u00fcbingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.","volume":"53","author":"H Singh-Jasuja","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs.","volume":"50","author":"H Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","article-title":"Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.","volume":"152","author":"KC Parker","year":"1994","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"W194","DOI":"10.1093\/nar\/gkl284","article-title":"SVMHC: a server for prediction of MHC-binding peptides.","volume":"34","author":"P D\u00f6nnes","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0039.2003.00112.x","article-title":"Sensitive quantitative predictions of peptide-MHC binding by a \u2018Query by Committee\u2019 artificial neural network approach.","volume":"62","author":"S Buus","year":"2003","journal-title":"Tissue Antigens"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.","volume":"12","author":"M Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/bioinformatics\/bth100","article-title":"Improved prediction of MHC class I and class II epitopes using a novel gibbs sampling approach.","volume":"20","author":"M Nielsen","year":"2004","journal-title":"Bioinformatics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0264-410X(98)00173-X","article-title":"Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix.","volume":"16","author":"JR Schafer","year":"1998","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00251-005-0798-y","article-title":"Automated generation and evaluation of specific mhc binding predictive tools: Arb matrix applications.","volume":"57","author":"HH Bui","year":"2005","journal-title":"Immunogenetics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.","volume":"6","author":"B Peters","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.","volume":"8","author":"M Nielsen","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices.","volume":"17","author":"T Sturniolo","year":"1999","journal-title":"Nat Biotechnol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.pcbi.0020065","article-title":"A community resource benchmarking predictions of peptide binding to MHC-I molecules.","volume":"2","author":"B Peters","year":"2006","journal-title":"PLoS Comput Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.vaccine.2005.01.097","article-title":"HIV vaccine development by computer assisted design: the GAIA vaccine.","volume":"23","author":"ASD Groot","year":"2005","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.molimm.2006.06.003","article-title":"Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.","volume":"44","author":"T Vider-Shalit","year":"2007","journal-title":"Mol Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.","volume":"13","author":"W Fischer","year":"2007","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1371\/journal.pcbi.0030075","article-title":"Coping with viral diversity in HIV vaccine design.","volume":"3","author":"DC Nickle","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"ref29","article-title":"Theory of linear and integer programming","author":"A Schrijver","year":"1986"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/bioinformatics\/bti144","article-title":"Solving and analyzing side-chain positioning problems using linear and integer programming.","volume":"21","author":"CL Kingsford","year":"2005","journal-title":"Bioinformatics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/bioinformatics\/bth485","article-title":"The Los Alamos hepatitis C sequence database.","volume":"21","author":"C Kuiken","year":"2005","journal-title":"Bioinformatics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput.","volume":"32","author":"RC Edgar","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1110\/ps.051352405","article-title":"Integrated modeling of the major events in the MHC class I antigen processing pathway.","volume":"14","author":"P D\u00f6nnes","year":"2005","journal-title":"Protein Sci"},{"key":"ref34","article-title":"ILOG CPLEX, version 9.1.","year":"2005"},{"key":"ref35","article-title":"Mosek."},{"key":"ref36","article-title":"Constraint Integer Programming.","author":"T Achterberg","year":"2007"},{"key":"ref37","doi-asserted-by":"crossref","article-title":"SCIP (Solving Constraint Integer Programs).","author":"T Achterberg","DOI":"10.1007\/s12532-008-0001-1"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design.","volume":"8","author":"RA Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0952-7915(03)00083-9","article-title":"Epitope-based vaccines: an update on epitope identification, vaccine design and delivery.","volume":"15","author":"A Sette","year":"2003","journal-title":"Curr Opin Immunol"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T08:39:41Z","timestamp":1684831181000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000246"}},"subtitle":[],"editor":[{"given":"Rob J.","family":"De Boer","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2008,12,26]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2008,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000246","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,26]]}}}